Study on c-Met Targeted PET/CT Imaging in NSCLC

Inclusion Criteria

• •1. Age range 18-75 years, open to both male and female participants;
• •2. Normal hepatic/renal function and cardiac function;
• •3. Expected survival of at least 12 weeks;
• •4. Good adherence to follow-up;
• •5. Presence of at least one measurable target lesion according to RECIST 1.1 criteria;
• •6. Women of childbearing age (15-49 years) must undergo a pregnancy test within seven days prior to the commencement of the study and test negative; sexually active male and female participants must agree to utilize effective contraception to prevent pregnancy during the study and for three months following the final examination;
• •7. Patients for whom a clinical physician recommends PET/CT scans for the diagnosis and staging of tumors;
• •8. Participants must fully understand and voluntarily agree to participate in the study, and must sign an informed consent form.